Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? (2022)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)01536-7
PubMed Identifier: 36088945
Publication URI: http://europepmc.org/abstract/MED/36088945
Type: Journal Article/Review
Volume: 400
Parent Publication: Lancet (London, England)
Issue: 10355
ISSN: 0140-6736